Comment
doi: 10.1371/journal.pmed.0030164.
Epub 2006 Apr 4.
Mathematical model of HPV provides insight into impacts of risk factors and vaccine
Affiliations
- PMID: 16573363
- PMCID: PMC1434498
- DOI: 10.1371/journal.pmed.0030164
Item in Clipboard
Comment
Mathematical model of HPV provides insight into impacts of risk factors and vaccine
PLoS Med.
2006 May.
Abstract
Kim discusses a study by Barnabas and colleagues in PLoS Medicine in which the researchers used a mathematical model to assess the effect of sexual transmission of HPV 16 in a Finnish population.
Conflict of interest statement
Comment on
-
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.PLoS Med. 2006 May;3(5):e138. doi: 10.1371/journal.pmed.0030138. Epub 2006 Apr 4. PLoS Med. 2006. PMID: 16573364 Free PMC article.
Similar articles
-
Current clinical trials of HPV vaccines.Oncology (Williston Park). 2004 Jun;18(7):859-60, 862. Oncology (Williston Park). 2004. PMID: 15255170 No abstract available.
-
[HPV vaccination--a possibility for prevention of cervical cancer].Duodecim. 2002;118(21):2159-60. Duodecim. 2002. PMID: 12486951 Finnish. No abstract available.
-
God's gift to women: the human papillomavirus vaccine.Immunity. 2006 Aug;25(2):179-84. doi: 10.1016/j.immuni.2006.08.002. Immunity. 2006. PMID: 16920633
-
Prevention strategies of cervical cancer in the HPV vaccine era.Gynecol Oncol. 2006 Oct;103(1):21-4. doi: 10.1016/j.ygyno.2006.07.019. Epub 2006 Aug 17. Gynecol Oncol. 2006. PMID: 16919714 Review. No abstract available.
-
HPV vaccines.Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):279-93. doi: 10.1016/j.bpobgyn.2005.10.011. Epub 2005 Dec 13. Best Pract Res Clin Obstet Gynaecol. 2006. PMID: 16356772 Review.
Cited by
-
Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach.PLoS One. 2012;7(11):e49614. doi: 10.1371/journal.pone.0049614. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185383 Free PMC article.
-
Emerging vaccine informatics.J Biomed Biotechnol. 2010;2010:218590. doi: 10.1155/2010/218590. Epub 2011 Jun 15. J Biomed Biotechnol. 2010. PMID: 21772787 Free PMC article. Review.
References
-
- Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, et al. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer. 2003;106:896–904. - PubMed
-
- Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004;96:604–615. - PubMed
-
- Garnett GP, Waddell HC. Public health paradoxes and the epidemiological impact of an HPV vaccine. J Clin Virol. 2000;19:101–111. - PubMed
